Ken Griffin Becton Dickinson & CO Call Options Transaction History

Citadel Advisors LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$221.47 - $242.41 $7.64 Million - $8.36 Million	34,500 Added 27.29%	160,900 $38.8 Million
Q2 2024 Aug 14, 2024	SELL	$225.07 - $246.17 $17.3 Million - $19 Million	-77,000 Reduced 37.86%	126,400 $29.5 Million
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $19.4 Million - $20.6 Million	-83,200 Reduced 29.03%	203,400 $50.3 Million
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $2.58 Million - $2.97 Million	-11,100 Reduced 3.73%	286,600 $69.9 Million
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $21 Million - $23.4 Million	82,400 Added 38.27%	297,700 $77 Million
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $17.8 Million - $19.8 Million	-74,800 Reduced 25.78%	215,300 $56.8 Million
Q1 2023 May 15, 2023	SELL	$229.71 - $259.35 $36 Million - $40.6 Million	-156,600 Reduced 35.06%	290,100 $71.8 Million
Q4 2022 Feb 14, 2023	SELL	$218.29 - $256.91 $218,290 - $256,910	-1,000 Reduced 0.22%	446,700 $114 Million
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $16.4 Million - $85 Million	321,600 Added 255.04%	447,700 $99.8 Million

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.7B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.